Paid Clinical Trials Eugene

Discover 143 paid clinical trials in Eugene, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 143

Rinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)Rinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Recruiting

PHASE1

PHASE2

Sponsor:

Genmab

Location:

Eugene OR, Portland OR, Santa Rosa CA, West Valley City UTshow 26 more

Code:

NCT05579366

Conditions

Platinum-Resistant Ovarian Cancer

Platinum Sensitive Ovarian Cancer (PSOC)

High Grade Epithelial Ovarian Cancer

High Grade Serous Ovarian Cancer

Primary Peritoneal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rina-S

Carboplatin

Bevacizumab

Pembrolizumab

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Roseburg OR, Surrey, Vancouver, Lincoln CAshow 126 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Roseburg OR, Grants Pass OR, Medford OR, Boise IDshow 196 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic SyndromesA Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

Recruiting

PHASE2

Sponsor:

Akeso

Location:

Eugene OR, Los Angeles CA, Aurora CO, Dallas TXshow 10 more

Code:

NCT06196203

Conditions

Higher-risk Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AK117

Placebo

Azacitidine

A Randomized Trial to Evaluate Sequential vs Simultaneous PatchingA Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Recruiting

PHASE3

Sponsor:

Jaeb Center for Health Research

Location:

Albany OR, Portland OR, Seattle WA, Boise IDshow 54 more

Code:

NCT04378790

Conditions

Amblyopia

Eligibility Criteria

Sex: All

Age: 3 - 13

Healthy Volunteers: Not accepted

Interventions

Patching

Glasses

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

Recruiting

Sponsor:

Boston Scientific Corporation

Location:

Eugene OR, Tualatin OR, Seattle WA, Spokane WAshow 23 more

Code:

NCT04192591

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 45+

Healthy Volunteers: Not accepted

Interventions

Superion™ IDS device

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant ChemotherapyEpidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Recruiting

Sponsor:

BioNTech SE

Location:

Eugene OR, Vancouver WA, Spokane WA, Greenbrae CAshow 13 more

Code:

NCT04813627

Conditions

Colorectal Cancer Stage II

Colorectal Cancer Stage III

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Regular blood sample collection for ctDNA assessment

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims StudyMILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Eugene OR, Springfield OR, Albany OR, Salem ORshow 1071 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur FracturesTranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures

Recruiting

Sponsor:

Good Samaritan Regional Medical Center, Oregon

Location:

Corvallis OR

Code:

NCT02580227

Conditions

Hip Fractures

Surgical Blood Loss

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tranexamic Acid

Placebo

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Recruiting

PHASE2

Sponsor:

Allogene Therapeutics

Location:

Eugene OR, Portland OR, Seattle WA, Sacramento CAshow 33 more

Code:

NCT06500273

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemacabtagene ansegedleucel

ALLO-647

Fludarabine

Cyclophosphamide